NCT00405249View on ClinicalTrials.gov

Safety Study of Elvucitabine in HIV-1 Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
HIV Infections
Interventions
DRUG

elvucitabine

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT00405249 - Safety Study of Elvucitabine in HIV-1 Subjects | Biotech Hunter | Biotech Hunter